Laboratorios Farmacéuticos Rovi SA (41L)
XSTU
Real-time Data
06:00 AM
Day's Range
59.3052 wk Range
52.85Overview - 41L - Laboratorios Farmacéuticos Rovi SA
Key Statistics
Valuation
Enterprise Value
4.10B
P/E (Trailing)
121.98
Price / Sales (TTM)
5.49
EV / EBITDA
18.93
Profitability
Gross Margin
68.67%
Profit Margin
64.92%
Operating Margin
24.99%
Return on Assets
14.69%
Return on Equity
20.79%
Ownership
Shares Outstanding
51.14M
Price stats
50-Day Avg
65.73
200-Day Avg
58.75
Dividends
Frequency
Annual
Market Cap - 41L - Laboratorios Farmacéuticos Rovi SA
Peers - 41L - Laboratorios Farmacéuticos Rovi SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XSTU.
- 41LXSTULaboratorios Farmacéuticos Rovi SA4.08BMarket Cap+7.72%52-week change119.22P/E (Trailing)64.92%Profit Margin
- H6DXSTUHaleon Plc - ADR72.13BMarket Cap+2.35%52-week change23.61P/E (Trailing)64.18%Profit Margin
- MRKCXSTUMerck KGaA – Sponsored ADR59.12BMarket Cap+21.17%52-week change23.05P/E (Trailing)11.21%Profit Margin
- D8Y0XSTUSandoz Group AG ADR33.96BMarket Cap+32.05%52-week change62.80P/E (Trailing)5.53%Profit Margin
- 08HHXSTUShanghai Fosun Pharmaceutical Group Co., Ltd.4.97BMarket Cap-20.35%52-week change11.06P/E (Trailing)8.21%Profit Margin
- HM6AXSTUHypera S.A. Sponsored ADR2.39BMarket Cap+12.28%52-week change7.73P/E (Trailing)19.82%Profit Margin
- 2TZXSTUTianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.1.66BMarket Cap-14.91%52-week change15.43P/E (Trailing)17.96%Profit Margin
Profile Summary - 41L - Laboratorios Farmacéuticos Rovi SA
About
Laboratorios Farmacéuticos Rovi SA is a Spanish biotechnology and pharmaceutical company specializing in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. Founded in 1946, it operates through two primary segments: Manufacturing, focused on contract development and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
